NASDAQ:COCH

Envoy Medical (COCH) Stock Price, News & Analysis

Envoy Medical logo
$6.72 +0.02 (+0.22%)
As of 03:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Envoy Medical Stock (NASDAQ:COCH)

Advanced

Key Stats

Today's Range
$6.50
▼
$6.85
50-Day Range
$5.96
▼
$7.43
52-Week Range
$3.63
▼
$9.54
Volume
21,526 shs
Average Volume
38,842 shs
Market Capitalization
$52.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
Consensus Rating
Hold

Company Overview

Envoy Medical is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss.

Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss. Acclaim remains investigational and is not approved for commercial use.

AI Generated. May Contain Errors.

Envoy Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

COCH MarketRank™: 
3.082557502735 of 5 stars

Envoy Medical scored higher than 62% of companies evaluated by MarketBeat, and ranked 341st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envoy Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Envoy Medical has a consensus price target of $21.00, representing about 207.7% upside from its current price of $6.82.

  • Amount of Analyst Coverage

    Envoy Medical has only been the subject of 3 research reports in the past 90 days.

  • Read more about Envoy Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Envoy Medical are expected to grow in the coming year, from ($2.61) to ($2.25) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    1.26% of the float of Envoy Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Envoy Medical has a short interest ratio ("days to cover") of 2.67, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envoy Medical has recently decreased by 84.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Envoy Medical does not currently pay a dividend.

  • Dividend Growth

    Envoy Medical does not have a long track record of dividend growth.

  • News Sentiment

    Envoy Medical has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • MarketBeat Follows

    2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envoy Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    7.20% of the stock of Envoy Medical is held by insiders.

  • Percentage Held by Institutions

    8.59% of the stock of Envoy Medical is held by institutions.

  • Read more about Envoy Medical's insider trading history.
Receive COCH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COCH Stock News Headlines

FY2026 EPS Forecast for Envoy Medical Increased by Analyst
Are Tesla and SpaceX Going Bankrupt?
Tesla and SpaceX shares crashed right after Democrats took the House and the Senate in the midterm election. Elon Musk backed President Trump and donated millions to Republicans, and many believe he will become a political target. Brownstone Research founder Jeff Brown has seen Musk's new technology on camera. He says he is more convinced than ever that nothing can stop the coming Elon Musk revolution.tc pixel
HC Wainwright Reaffirms Buy Rating for Envoy Medical (NASDAQ:COCH)
Envoy (COCH) Q3 2026 Earnings Call Transcript
See More Headlines

COCH Stock Analysis - Frequently Asked Questions

Envoy Medical's stock was trading at $6.6110 on January 1st, 2026. Since then, COCH shares have increased by 3.2% and is now trading at $6.8240.

Envoy Medical, Inc. (NASDAQ:COCH) issued its earnings results on Thursday, November, 5th. The company reported ($0.50) earnings per share for the quarter, topping analysts' consensus estimates of ($0.67) by $0.17. The business earned $66 thousand during the quarter, compared to the consensus estimate of $85 thousand.

Envoy Medical shares reverse split before market open on Monday, October 26th 2026.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, October 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Envoy Medical's top institutional shareholders include Nantahala Capital Management LLC (99.46%). Insiders that own company stock include Glen A Taylor, Charles Brynelsen, Mona Chetan Patel, Brent T Lucas, Robert Potashnick and Susan Kantor.
View institutional ownership trends
.

Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Grab (GRAB), Reviva Pharmaceuticals (RVPH), Sintx Technologies (SINT), Archer Aviation (ACHR), Allurion Technologies (ALUR), Virgin Galactic (SPCE) and AT&T (T).

Company Calendar

Last Earnings
11/05/2026
Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:COCH
CIK
1840877
Fax
N/A
Employees
47
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$18.00
Potential Upside/Downside
+212.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.76 million
Net Margins
-9,026.41%
Pretax Margin
-9,026.41%
Return on Equity
N/A
Return on Assets
-112.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.21
Quick Ratio
1.10

Sales & Book Value

Annual Sales
$231 thousand
Price / Sales
225.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.20) per share
Price / Book
-33.58

Miscellaneous

Outstanding Shares
7,745,000
Free Float
7,187,000
Market Cap
$52.01 million
Optionable
Not Optionable
Beta
2.03
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:COCH) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners